Description: ApicHope Pharmaceutical Co., Ltd, together with its subsidiaries, engages in the research and development, production, and sale of pharmaceutical products. It offers anti-infection, pediatric, cardiovascular, genitourinary, respiratory, liver and digestion, and dermatological products, as well as anti-inflammatory and analgesic products. The company was formerly known as Yipinhong Pharmaceutical Co.,Ltd and changed its name to ApicHope Pharmaceutical Co., Ltd in December 2021. ApicHope Pharmaceutical Co., Ltd was founded in 2002 and is based in Guangzhou, China.
Home Page: www.gdyph.com
No. 27, Yunrun Building
Guangzhou,
510320
China
Phone:
86 20 2887 7666
Officers
| Name | Title |
|---|---|
| Mr. Hanxiong Li | Chairman of Directors & GM |
| Mr. Huixing Zhang | Chief Financial Officer |
| Mr. Xiaohua Xie | Deputy GM & Sec. of the Board of Directors |
| Ms. Zhihong Yan | Deputy Gen. Mang. |
| Ms. Dongling Yang | Deputy GM & Non-Independent Director |
| Mr. Mingyuan Zhang | Board Sec. |
Exchange: SHE
Country: CN
Currency: Renminbi (¥)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 38.28 |
| Price-to-Book MRQ: | 4.8472 |
| Price-to-Sales TTM: | 4.5556 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 1079 |